Business
Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance
LOUISVILLE, Ky., February 11, 2026--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share (EPS) for the quarter ended December 31, 2025 (4Q25) versus the quarter ended December 31 31, 2024 (4Q24) and for the year ended December 31, 2025 (FY 2025) versus the year ended December 31, 2024 (FY 2024) as noted in the tables below.
About this update from Humana Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/d789fff78b0544cc5d9c06bca29e8eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1Evg6OxwKr_FHVkUUMFssg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d789fff78b0544cc5d9c06bca29e8eff","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/y4DXOoRKwAQNGlaxkFwLpg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/d789fff78b0544cc5d9c06bca29e8eff","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations","length":280,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent'","length":220,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of mitigation","length":229,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Anticipates FY 2026 individual Medicare Advantage membership growth of 'approximately 25 percent' over 2025; driven by new sales and improved retention from the company's customer-led benefit strategy and changes to its customer service approach","length":257,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Continued growth in the CenterWell and Medicaid platforms","length":57,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Growth of 100,600 patients, or over 25 percent, in CenterWell Senior Primary Care during 2025, including approximately 32,000 patients ...